Market Tracker

04/23 12:06pm ET
4.22
Real-Time Quote
 -0.09 / -2.09%
Today’s Change
1.68
Today|||52-Week Range
6.95
-17.58%
Year-to-Date

Today’s Trading

Previous close4.31
Today’s open4.36
Day’s range4.07 - 4.36
Volume1,227,282
Average volume (3 months)4,812,770
Market cap$844.6M
Dividend yield--
Data as of 11:51am ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)+4.52%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book4.15

Competitors

 Today’s
change
Today’s
% change
SZYMSolazyme Inc-0.01-0.09%
FMIFoundation Medicine ...-1.07-3.84%
HALOHalozyme Therapeutic...-0.11-1.40%
RLYPRelypsa Inc-0.80-3.09%
Data as of 12:05pm ET, 04/23/2014

Financials

Next reporting dateMay 12, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
SVP
Barclay A. Phillips
Corporate headquarters
Rockville, Maryland

Forecasts